Cargando…
Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis
INTRODUCTION: Loricrin is usually observed in abundance in keratinizing epithelium in response to mechanical stress, which may be associated with development and malignant transformations in conditions such as oral submucous fibrosis (OSMF). Therefore, understanding of various molecular mechanisms a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595509/ https://www.ncbi.nlm.nih.gov/pubmed/33149468 http://dx.doi.org/10.4103/jpbs.JPBS_79_20 |
_version_ | 1783601891683336192 |
---|---|
author | Mahapatra, Niva Dash, Kailash C Bhuyan, Lipsa Panda, Abikshyeet Behura, Shyam S Mishra, Pallavi |
author_facet | Mahapatra, Niva Dash, Kailash C Bhuyan, Lipsa Panda, Abikshyeet Behura, Shyam S Mishra, Pallavi |
author_sort | Mahapatra, Niva |
collection | PubMed |
description | INTRODUCTION: Loricrin is usually observed in abundance in keratinizing epithelium in response to mechanical stress, which may be associated with development and malignant transformations in conditions such as oral submucous fibrosis (OSMF). Therefore, understanding of various molecular mechanisms associated with difference in gene expressions between OSMF and that of normal oral tissue is important. AIM: The aim of this study was to evaluate of the efficacy of loricrin as a diagnostic marker in patients with OSMF. MATERIALS AND METHODS: Fifty formalin-fixed paraffin-embedded tissue blocks were obtained from the archives of the department. The study sample was grouped into two groups of normal mucosa (group I; n = 20) and OSMF (group II; n = 30) specimens. The study tissues were immunohistochemically stained with loricrin antibody and were further graded on basis of staining intensity. RESULTS: Loricrin immunostaining was observed significantly more in OSMF cases and even in stratum granulosum in comparison to normal mucosa. CONCLUSION: Loricrin can act as an early indicator and a prognostic marker for detection of deleterious changes within epithelium in OSMF. |
format | Online Article Text |
id | pubmed-7595509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-75955092020-11-03 Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis Mahapatra, Niva Dash, Kailash C Bhuyan, Lipsa Panda, Abikshyeet Behura, Shyam S Mishra, Pallavi J Pharm Bioallied Sci Original Article INTRODUCTION: Loricrin is usually observed in abundance in keratinizing epithelium in response to mechanical stress, which may be associated with development and malignant transformations in conditions such as oral submucous fibrosis (OSMF). Therefore, understanding of various molecular mechanisms associated with difference in gene expressions between OSMF and that of normal oral tissue is important. AIM: The aim of this study was to evaluate of the efficacy of loricrin as a diagnostic marker in patients with OSMF. MATERIALS AND METHODS: Fifty formalin-fixed paraffin-embedded tissue blocks were obtained from the archives of the department. The study sample was grouped into two groups of normal mucosa (group I; n = 20) and OSMF (group II; n = 30) specimens. The study tissues were immunohistochemically stained with loricrin antibody and were further graded on basis of staining intensity. RESULTS: Loricrin immunostaining was observed significantly more in OSMF cases and even in stratum granulosum in comparison to normal mucosa. CONCLUSION: Loricrin can act as an early indicator and a prognostic marker for detection of deleterious changes within epithelium in OSMF. Wolters Kluwer - Medknow 2020-08 2020-08-28 /pmc/articles/PMC7595509/ /pubmed/33149468 http://dx.doi.org/10.4103/jpbs.JPBS_79_20 Text en Copyright: © 2020 Journal of Pharmacy and Bioallied Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Mahapatra, Niva Dash, Kailash C Bhuyan, Lipsa Panda, Abikshyeet Behura, Shyam S Mishra, Pallavi Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis |
title | Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis |
title_full | Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis |
title_fullStr | Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis |
title_full_unstemmed | Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis |
title_short | Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis |
title_sort | evaluation of the efficacy of loricrin as a diagnostic marker in patients with oral submucous fibrosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595509/ https://www.ncbi.nlm.nih.gov/pubmed/33149468 http://dx.doi.org/10.4103/jpbs.JPBS_79_20 |
work_keys_str_mv | AT mahapatraniva evaluationoftheefficacyofloricrinasadiagnosticmarkerinpatientswithoralsubmucousfibrosis AT dashkailashc evaluationoftheefficacyofloricrinasadiagnosticmarkerinpatientswithoralsubmucousfibrosis AT bhuyanlipsa evaluationoftheefficacyofloricrinasadiagnosticmarkerinpatientswithoralsubmucousfibrosis AT pandaabikshyeet evaluationoftheefficacyofloricrinasadiagnosticmarkerinpatientswithoralsubmucousfibrosis AT behurashyams evaluationoftheefficacyofloricrinasadiagnosticmarkerinpatientswithoralsubmucousfibrosis AT mishrapallavi evaluationoftheefficacyofloricrinasadiagnosticmarkerinpatientswithoralsubmucousfibrosis |